Sign in
4

Changes in Ownership

ACADIA PHARMACEUTICALS INC Filed Acc 0001604689-26-000006

Options or other derivatives

  • Director acquired 17,275 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Poole Jonathan Director 2026-03-03 Grant or award · Director Stock Options (Right to Buy) +7,482 7,482 D
Poole Jonathan Director 2026-03-03 Grant or award · Director Stock Options (Right to Buy) +3,565 3,565 D
Poole Jonathan Director 2026-03-03 Grant or award · Restricted Stock Units +4,218 4,218 D
Poole Jonathan Director 2026-03-03 Grant or award · Restricted Stock Units +2,010 2,010 D
Loading xslF345X06/form4-03202026_100313.xml…